Surprising origins for a rare cancer
It’s been enormously difficult to pinpoint the cause of many cancers—and many seem to have…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Social inequalities widen after a breast cancer
When it comes to health, inequalities can be seen at every level for women with…
Researchers uncover mechanism that fuels growth of aggressive B-cell lymphoma
Researchers from the University of Helsinki and HUS investigated the effects of recurring mutations in…
How targeted nutrients can target cancer
An international research team has discovered a new way to effectively treat cancer, by using…
Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients
An analysis of data from a randomised clinical trial for patients with stage 3 colon…
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a…
Children genetically prone to cancer benefit from early standardised surveillance
Recent advances in genomic sequencing have revealed that 5–15% of children with cancer have an…
New urine test can improve accuracy for early detection of bladder cancer in patients with haematuria
One of the first signs of bladder cancer can be blood in the urine (hematuria).…
EHA 2024: Updated linvoseltamab data showcase continued deepening of responses in patients with heavily pre-treated multiple myeloma
The 14-month median follow-up data from the pivotal Phase 1/2 LINKER-MM1 trial of linvoseltamab in…
Pancreatic cancer’s cellular amnesia
Things aren’t always as they seem. Take pancreatic cancer, for example. In up to one…